Replimune Group Inc (REPL)

Replimune Group Inc (REPL) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $1.3B; returns 1 day -4.4%, 1 week +5.5%, 1 year +36.1%.

Replimune Group Inc (REPL) is a clinical-stage biotechnology company focused on developing oncolytic immunotherapies, utilizing a proprietary Immulytic platform to engineer viruses that selectively replicate in and kill tumor cells while stimulating anti-tumor immune responses.

Groups REPL belongs to

• Biotechnology
• Clinical Stage Biotech
• Oncology
• Healthcare
• Cancer Therapeutics
• Immunotherapy
• Clinical Stage
• Life Sciences
• Biopharmaceutical
• R&D

REPL financial model: income statement, cash flow and balance sheet